ライフサイエンスコーパス: molecular pathology

1 whose primary interest is in another area of molecular pathology.

2 n RTT and TSC have allowed dissection of the molecular pathology.

3 s, with the aim of identifying approaches to molecular pathology.

4 f depressed subjects with a more homogeneous molecular pathology.

5 les in OA and provide novel insights into OA molecular pathology.

6 tempts will be crucial to the advancement of molecular pathology.

7 esource for dissecting mechanisms driving AD molecular pathology.

8 gical dysfunction in terms of the underlying molecular pathology.

9 wed by a loss of synapses in response to the molecular pathology.

10 disease have been derived from genetics and molecular pathology.

11 to confirm the mediation of synaptic loss by molecular pathology.

12 the pursuit of novel avenues of research in molecular pathology.

13 ular mechanisms of PP, STN1 and STN1-related molecular pathology.

14 n improved understanding of subtype-specific molecular pathology.

15 ion of the spectrin cytoskeleton is a common molecular pathology.

16 ptional dysregulation and cell-type-specific molecular pathology.

17 ique, as well as insight into the underlying molecular pathology.

18 so undertaking brain imaging and analysis of molecular pathology.

19 RN caused by infection with EBV confirmed by molecular pathology.

20 outcomes, such as cellular epidemiology and molecular pathology.

21 oteomic study of a broad range of targets in molecular pathology.

22 e early stages, despite distinct patterns of molecular pathology.

23 netics and Genomics, and the Association for Molecular Pathology(9) for clinical classification of BR

24 College of Medical Genetics-Association for Molecular Pathology (ACMG-AMP) criteria is crucial.

25 Medical Genetics and Genomics/Association of Molecular Pathology (ACMG/AMP) classification criteria f

26 enetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) for interpreting sequence

27 lege of Medical Genetics and Association for Molecular Pathology (ACMG/AMP) guidelines for the ataxia

28 enetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) interpretation guidelines

29 enetics and Genomics and the Association for Molecular Pathology (ACMG/AMP), following ClinGen recomm

30 enetics and Genomics and the Association for Molecular Pathology (ACMG/AMP).

31 Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) framework for classifying vari

32 Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) guideline on molecular testing

33 Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) guidelines is challenging and

34 and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published guidelines for the a

35 and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published updated standards an

36 etics and Genomics (ACMG) and Association of Molecular Pathology (AMP) recently published important n

37 Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) variant classification system

38 American Pathologists (CAP), Association for Molecular Pathology (AMP), and the American Society of C

39 e of Medical Genetics (ACMG)/Association for Molecular Pathology (AMP)-like variant classification fr

40 tween hippocampal hyperactivity and early AD molecular pathology (amyloid-beta and tau accumulation)

41 isease (AD) is characterized by two hallmark molecular pathologies: amyloid abeta1-42 and Tau neurofi

42 of histopathologic, immunohistochemical, and molecular pathology analyses at different time points du

43 The complex nature of molecular pathology and biology necessitates biostatisti

44 ryogenesis furthers our understanding of LCC molecular pathology and cerebral vascular homeostasis.

45 edical Genetics and Genomics/Association for Molecular Pathology and ClinGen's MYH7-cardiomyopathy sp

46 y, advancing integrative structural biology, molecular pathology and drug development.

47 tructural biology, and with implications for molecular pathology and drug discovery.

48 ts in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer.

49 These findings provide insights into CACNA1A molecular pathology and highlight the potential for prec

50 r disease characterization and monitoring in molecular pathology and is expected to become a central

51 A genetic diagnosis informs on molecular pathology and may direct targeted treatments a

52 to be responsible for various aspects of the molecular pathology and memory impairment in mouse model

53 st that ApoE4 may increase susceptibility to molecular pathology and modulate the anatomic pattern of

54 models, but these models do not reflect the molecular pathology and progressive nature of PD that wo

55 Finally, we discuss how progress in molecular pathology and radiation biology may provide no

56 ons of responsibility in AMP (Association of Molecular Pathology) and is Chair of the CLSI's Area Com

57 new findings regarding the cellular origins, molecular pathology, and clinical features of histiocyti

58 plied WTA to biological questions in cancer, molecular pathology, and developmental biology.

59 his paradigm: epidemiology, pathophysiology, molecular pathology, and genetics.

60 edical Genetics and Genomics/Association for Molecular Pathology, APOGEE 2 features an improved machi

61 Degeneracy means that several different molecular pathologies are individually sufficient to cau

62 es first insights into distinct cellular and molecular pathologies associated with trait- and state-M

63 tor of Clinical Laboratories and Director of Molecular Pathology at the Medical University of South C

64 d virus type 8-RS1 (AAV8-RS1) vector rescues molecular pathology at the photoreceptor-depolarizing bi

65 edical Genetics and Genomics/Association for Molecular Pathology Bayesian classification framework in

66 edical Genetics and Genomics/Association for Molecular Pathology benign and pathogenic functional cri

67 Molecular pathology, biochemistry, genetics, and longitu

68 brain atrophy reflects not only the primary molecular pathology but also co-occurring proteinopathie

69 Molecular pathology cannot determine the overall impact

70 lege of Medical Genetics and Association for Molecular Pathology CDH1 guidelines (version 2).

71 describe insights into the cells of origin, molecular pathology, clinical features, and treatment st

72 rocesses, and standards for all cellular and molecular pathology components of the trial, including a

73 sensus reporting guidelines for cellular and molecular pathology content in clinical trial protocols

74 Medical Genetics and Genomics/Association of Molecular Pathology criteria that were deemed not applic

75 enetics and Genomics and the Association for Molecular Pathology criteria, utilizing data from the Do

76 enetics and Genomics and the Association for Molecular Pathology criteria.

77 ege of Genetics and Genomics/Association for Molecular Pathology criteria.

78 enetics and Genomics and the Association for Molecular Pathology criteria.

79 lesions of the pancreas and their underlying molecular pathology, current management guidelines for p

80 g point can be reached via several different molecular pathologies (degeneracy).

81 Recent advances in molecular pathology, diagnosis, and management of patien

82 es a number of recent advances regarding the molecular pathology, diagnosis, localization, and manage

83 Innovative patient-centric, molecular pathology-driven clinical trial approaches are

84 de first insights into distinct cellular and molecular pathologies, druggable mechanisms associated w

85 d assessment of amyloid burden, gliosis, and molecular pathology during disease progression.

86 r inherited, but little is known about their molecular pathology, especially the sporadic forms.

87 recent decision in the case Association for Molecular Pathology et al. v.

88 induced cachexia model based on clinical and molecular pathology findings.

89 There is no plausible molecular pathology for disease phenotypic heterogeneity

90 e lesions is an essential component of their molecular pathology, funding agencies should adopt polic

91 mical carcinogenesis, immunology, pathology, molecular pathology, genetics, oncology, and surgical on

92 edical Genetics and Genomics/Association for Molecular Pathology guidelines for clinical classificati

93 lege of Medical Genetics and Association for Molecular Pathology guidelines for the interpretation of

94 edical Genetics and Genomics/Association for Molecular Pathology guidelines in 392 patients with susp

95 edical Genetics and Genomics/Association for Molecular Pathology guidelines; somatic mutation analysi

96 This progress in our understanding of the molecular pathology has set the stage for clinically mea

97 In addition, new developments in diagnostic molecular pathology have been used to more readily ident

98 The two primary molecular pathologies in Alzheimer's disease are amyloid

99 The underlying molecular pathology in a considerable proportion of thes

100 n all 118 exons of the gene to determine the molecular pathology in a patient with DEB.

101 One way to image the molecular pathology in Alzheimer's disease is by positro

102 Our data suggest shared and distinct molecular pathology in both disorders and propose potent

103 r downstream histopathological diagnoses and molecular pathology in both in vivo and ex vivo settings

104 highlight the importance of convergent glial molecular pathology in both the pathogenesis and phenoty

105 e also investigated the relationship between molecular pathology in cortical brain regions and synapt

106 correlates of this sex bias, we investigated molecular pathology in females and males using the 5XFam

107 ive biomarkers are urgently needed to detect molecular pathology in frontotemporal dementia (FTD) and

108 rom the degenerating medial temporal lobe or molecular pathology in functionally connected regions, a

109 idence for Elk-1 as a target for alleviating molecular pathology in HD.

110 This study shows that the molecular pathology in patients with the distinctive cli

111 on in liver or kidney is the primary site of molecular pathology in peripheral tissues, has not been

112 Histopathological staging of molecular pathology in post-mortem tissue lacks clinical

113 ionship between in vivo synaptic density and molecular pathology in primary tauopathies is key to und

114 bedside; and the challenges of implementing molecular pathology in the clinic.

115 single nucleus RNA sequencing to investigate molecular pathology in the cortex and striatum from R6/2

116 vo relationship between synaptic density and molecular pathology in the primary tauopathies of progre

117 ta2 plays in the glaucomatous changes to the molecular pathology in the trabecular meshwork, we emplo

118 Cerebral synaptic density and molecular pathology, in all participants, were estimated

119 Epidemiology, molecular pathology (including chemistry, biochemistry,

120 a number of clinical disorders with distinct molecular pathologies, including fragile X syndrome (FXS

121 Ideally, epidemiology and molecular pathology information together with experiment

122 In autism spectrum disorder (ASD), this molecular pathology involves the upregulation of microgl

123 Molecular pathology is certain to become important in th

124 ses of cancer death and clarification of its molecular pathology is highly prioritized.

125 opathy is rare, and our understanding of the molecular pathology is limited.

126 es in humans and mice, respectively, but the molecular pathology is unclear.

127 The new molecular pathology is yet another technique that can im

128 ing the respective roles of epidemiology and molecular pathology, it was noted that epidemiology allo

129 tis C virus (HCV) genotypes in a high-volume molecular pathology laboratory setting.

130 infectious disease testing done in a central molecular pathology laboratory under the leadership of a

131 infectious disease testing done in a central molecular pathology laboratory under the leadership of a

132 oups also differ in the associations between molecular pathology, neurodegeneration and cognitive per

133 h could partially account for the sex-biased molecular pathology observed in this dataset.

134 d microarray data integration to compare the molecular pathologies of PE-CVS and endometrial disorder

135 peptides might play an insidious role in the molecular pathologies of protein misfolding diseases.

136 then used the DII-VSD construct to probe the molecular pathology of 2 Brugada syndrome mutations (A73

137 Understanding the molecular pathology of a tumor and its linkage to behavi

138 Understanding the molecular pathology of AD during disease progression may

139 ration and are relevant to understanding the molecular pathology of ADLD.

140 ntiation programs and in the development and molecular pathology of allergic asthma.

141 nction of Matrin3 should help to clarify the molecular pathology of ALS and other diseases caused by

142 oligomers are critical early players in the molecular pathology of Alzheimer's disease (AD).

143 igomers is one of the earliest events in the molecular pathology of Alzheimer's Disease (AD).

144 his discovery further defines the underlying molecular pathology of ANE syndrome to include genetic v

145 sequent DNA damage is a key substrate in the molecular pathology of ARVC.

146 rovide a critical driver of the underpinning molecular pathology of autosomal dominant polycystic kid

147 illuminate common mechanisms, we discuss the molecular pathology of AxD astrocytes and compare that t

148 s of isoaspartate formation in cells and the molecular pathology of brain aging.

149 The molecular pathology of breast cancer is challenging due

150 ry epithelial cell types to the etiology and molecular pathology of breast disease.

151 ure cortical architecture and displays early molecular pathology of C9ORF72 ALS/FTD.

152 ests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberra

153 pplied an integrated approach to uncover the molecular pathology of cataract in Tdrd7-/- mice.

154 stablishing a paradigm for understanding the molecular pathology of CCS disease.

155 f recombinant DNA technology in defining the molecular pathology of common disorders and of diagnosti

156 s, it is important to consider that so far a molecular pathology of cortical GABAergic neurons appear

157 An enhanced understanding of the molecular pathology of disease gained from genomic studi

158 our understanding and interpretation of the molecular pathology of diseases such as cancer.

159 to be hardly any closer to understanding the molecular pathology of DM than when the mutation was fir

160 and, in humans, may also be involved in the molecular pathology of Down syndrome.

161 biophysical techniques, we characterize the molecular pathology of E46K-like alphaSyn mutants by stu

162 The molecular pathology of each variant was delineated using

163 n of helicase motif Ia but also provides the molecular pathology of FANCJ in related diseases.

164 Molecular pathology of forest trees for a long time lagg

165 perplasia, and could also be involved in the molecular pathology of GO.

166 an online resource for access to data on the molecular pathology of haemophilia A, replacing previous

167 r the cytoplasmic aggregation process in the molecular pathology of HD.

168 contribute to a deeper understanding of the molecular pathology of HHT [corrected] in particular and

169 Our findings define the molecular pathology of homozygous VP and suggest that mi

170 s review discusses new methods to define the molecular pathology of human disease with high-throughpu

171 o recapitulate distinct aspects of the broad molecular pathology of human MDD, with no one mouse mode

172 Vital insight into the molecular pathology of I-GS has been obtained from studi

173 Here, we present the molecular pathology of IFN-gamma exposure and its effect

174 Thus, understanding the molecular pathology of individual mutations has become i

175 Several groups have studied the molecular pathology of inherited breast cancer.

176 P, and suggest reasonable hypotheses for the molecular pathology of inherited prion diseases.

177 ogical human cerebrovasculature to study the molecular pathology of intracranial aneurysms.

178 The molecular pathology of intraductal papillary mucinous ne

179 ndings provide additional information to the molecular pathology of IRDs in Iran, hopefully contribut

180 SorL1, SorCS1)] have been implicated in the molecular pathology of late-onset AD.

181 e as a valuable model both to understand the molecular pathology of late-onset retinal degeneration a

182 To better understand the molecular pathology of LINCL, we conducted a genetic sur

183 ssion would facilitate identification of the molecular pathology of major depression.

184 searchers hope that further knowledge of the molecular pathology of malignant gliomas will result in

185 tions that are crucial for understanding the molecular pathology of many mutations that cause disease

186 Our results provide novel insight into the molecular pathology of microcephaly and establish a role

187 e precursor cells and of the stage-dependent molecular pathology of multiple sclerosis lesions releva

188 Understanding the molecular pathology of neurodevelopmental disorders shou

189 model provides a platform for dissecting the molecular pathology of oxidative damage in the outer ret

190 ography imaging is a tool to investigate the molecular pathology of PAH and its response to treatment

191 These data provide new insights into the molecular pathology of pancreatic cancer that may be use

192 al transcripts can provide insights into the molecular pathology of pancreatic cancer.

193 Little is known about the molecular pathology of PNES, much less about possible un

194 eta) signalling pathway is implicated in the molecular pathology of POAG.

195 While a definitive understanding of the molecular pathology of posttraumatic stress disorder (PT

196 The molecular pathology of precursor lesions leading to inva

197 tic nerve were pursued for insights into the molecular pathology of primary open-angle glaucoma (POAG

198 Better understanding of the molecular pathology of PSP has highlighted the importanc

199 inform our understanding of the brain-level molecular pathology of psychiatric disorders, including

200 complexes, a process that is central to the molecular pathology of S. aureus endocarditis.

201 is leading to a better understanding of the molecular pathology of sarcomas, which may eventually le

202 As a step towards understanding the molecular pathology of SCA8, we have defined the genomic

203 herefore be considered when interpreting the molecular pathology of single-gene disorders.

204 Molecular pathology of skeletal muscle was ameliorated i

205 ing, will increasingly be used to define the molecular pathology of specific cases diagnosed with dep

206 The molecular pathology of stress-related disorders remains

207 Understanding the molecular pathology of the adenoma is therefore importan

208 e single-cell RNA-sequencing (scRNA-seq) and molecular pathology of the comparative biology between h

209 a route to further our understanding of the molecular pathology of the condition.

210 There is a lack of information regarding the molecular pathology of the hippocampus in ASD.

211 MDD, the extent to which they reproduce the molecular pathology of the human syndrome remains unknow

212 In this work, we have explored the molecular pathology of the lethal form of EB-PA, and we

213 In addition to its role in the molecular pathology of the polyglutamine expansion disea

214 The type and molecular pathology of the thyroid tumors is changing wi

215 Major insights have been attained into the molecular pathology of the trinucleotide repeat neurodeg

216 tter understand the relationship between the molecular pathology of the variants and the disease.

217 To further explore the molecular pathology of this disease and to investigate p

218 s that will advance our understanding of the molecular pathology of this disease.

219 ces in our understanding of the genetics and molecular pathology of this group of diseases, as well a

220 to be highly informative in elucidating the molecular pathology of this highly malignant tumour type

221 Molecular pathology of thymomas is poorly understood.

222 our results, we propose a new model for the molecular pathology of tubulinopathies that may also ext

223 The molecular pathology of type 3 VWD has been similarly wel

224 th which to study DNA repair, as well as the molecular pathology of UV radiation-induced skin cancer.

225 ing these relationships may help clarify the molecular pathology of various cardiovascular disease st

226 The molecular pathology of VUs remains poorly understood, im

227 isease could either be caused by a spreading molecular pathology or by an initially focal pathology t

228 Currently, little is known about the molecular pathology or cell biology of SCC in RDEB.

229 on that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, det

230 The goal is to incorporate molecular pathology, performed on the same paraffin bloc

231 pproach represents a shift towards real-time molecular pathology, potentially reducing re-biopsies an

232 However, cellular and molecular pathology practices within trials have not bee

233 h a switch in spike initiation dynamics when molecular pathologies reach a tipping point (criticality

234 ity of immune cells facilitates discovery of molecular pathology remains unknown.

235 odents to recapitulate large portions of the molecular pathology seen in postmortem brain tissue of i

236 Molecular pathology services for colorectal cancer (CRC)

237 SL2-B isoform and confirm its involvement in molecular pathologies shared between many psychiatric di

238 highlights the importance of integration of molecular pathology signatures into clinical algorithms

239 that captures both the clinical severity and molecular pathology specific to Alzheimer's disease acro

240 romising new approach for large scale cancer molecular pathology studies.

241 While there is evidence that molecular pathologies, such as amyloid beta (Abeta), con

242 Molecular pathology, such as high-throughput genomic and

243 However, genomic, epigenomic and molecular pathology testings (for example, analyses for

244 ajor depression is reflected in a persistent molecular pathology that affects the amygdala, and suppo

245 ubtypes exist, yet little is known about the molecular pathology that drives the diversity in these t

246 -binding protein) identifies a novel type of molecular pathology that shows increasing accumulation i

247 Advances in molecular pathology, the development of targeted therapi

248 strophies type 1 (DM1) and DM2 cause complex molecular pathology, the features of which include accum

249 oad spectrum of Abeta-triggered, tau-related molecular pathology thereby contributing to synaptic res

250 However, the molecular pathology underlying ID-associated TRMT1 mutat

251 This provides new insights into the molecular pathology underlying muscular dystrophies and

252 e linking GARS mutations to CMT disease, the molecular pathology underlying the neuromuscular and sen

253 enerative diseases encompass a wide array of molecular pathologies unified by calpain dysregulation.

254 ing of 70 genes in 400 patients and explored molecular pathology using gene expression signature data

255 se before the Supreme Court, Association for Molecular Pathology v Myriad Genetics, Inc seeks to over

256 The Association for Molecular Pathology v Myriad Supreme Court decision will

257 e Court's recent decision in Association for Molecular Pathology v. Myriad Genetics, Inc. declared, f

258 enetics and Genomics and the Association for Molecular Pathology variant classification publication e

259 determine causal associations between these molecular pathologies, we suggest that the combination o

260 In the past 30 years, molecular pathology (which includes chemistry, biochemis

261 dementias has led to an understanding of the molecular pathology, which is also applicable to later-o

262 nal fluid biomarkers for Alzheimer's disease molecular pathology with clinical dementia diagnoses and

263 ic relationship between synaptic density and molecular pathology with synapse-rich regions vulnerable

264 formance correlated with Alzheimer's disease molecular pathology, with levels of CSF amyloid-beta and